All News about Crispr Therapeutics Ag
![](https://g.foolcdn.com/editorial/images/745046/biotech-stocks-doctors-research.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/Cathie_Wood_Ark_Invest_7.png?width=1200&height=800&fit=crop)
Cathie Wood Mops Up $8.1M Worth Of Zoom Stock After Q2 Earnings Beat, Sells Nvidia Shares In Excess Of $1M
August 22, 2023
Via Benzinga
Topics
Earnings
Exposures
Financial
![](https://g.foolcdn.com/editorial/images/744654/physician-giving-a-high-five-to-a-young-patient.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/cathie_wood_bz_ark_2.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2020/12/upgrade_1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
What 13 Analyst Ratings Have To Say About CRISPR Therapeutics
August 14, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/743238/dna-eye.jpg)
![](https://images.pexels.com/photos/4033021/pexels-photo-4033021.jpeg?auto=compress&cs=tinysrgb&dpr=1&w=500)
![](https://g.foolcdn.com/editorial/images/744384/scientist-looks-into-microscope-while-sitting-at-lab-bench.jpg)
![](https://investorplace.com/wp-content/uploads/2022/03/cathie-wood-stocks-1600.png)
![](https://g.foolcdn.com/editorial/images/743023/scientist-working-in-a-lab.jpeg)
![](https://g.foolcdn.com/editorial/images/743568/scientists-confer-at-lab-bench.jpg)
![](https://g.foolcdn.com/editorial/images/743333/three-investors-look-at-papers.jpg)
![](https://g.foolcdn.com/editorial/images/742367/growth-stock.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
The Latest Analyst Ratings for CRISPR Therapeutics
July 25, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/Cathie_Wood_Ark_Invest_5.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/03/biotech-stocks-2.jpg)
![](https://g.foolcdn.com/editorial/images/742997/healthcare.jpg)
![](https://g.foolcdn.com/editorial/images/742853/physician-giving-a-high-five-to-a-young-patient.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/08/08/warner_music_-_logo.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/08/08/energizer_holdings_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/04/pte_biotech_1600-1024x576.png)
![](https://investorplace.com/wp-content/uploads/2019/07/biotech1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/08/02/vrtx.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2023/02/buy-or-sell1600-1024x576.png)
![](https://g.foolcdn.com/editorial/images/741819/gettyimages-man-smiles-on-phone-at-computer.jpg)
![](https://g.foolcdn.com/editorial/images/740329/young-scientist-observing-with-microscope.jpg)
![](https://g.foolcdn.com/editorial/images/740120/physician-giving-a-high-five-to-a-young-patient.jpg)
![](https://g.foolcdn.com/editorial/images/740533/investor-tablet-in-boardroom-city-view.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.